Lunaphore Technologies: Paolo Ascierto, Jérôme Galon
Swiss life sciences company Lunaphore Technologies appointed Paolo Ascierto and Jérôme Galon, who are experts in immuno-oncology, to its new Scientific Advisory Board.
Ascierto is the director of the Department of Melanoma, Cancer Immunotherapy, and Development Therapeutics at the National Tumor Institute in Naples, Italy. He is a member of the Steering Committee of the Society of Melanoma Research and the board of directors of the Society of Immunotherapy of Cancer. He is also president of the Fondazione Melanoma Onlus and the Campania Society of ImmunoTherapy of Cancer.
Galon is the director of research at INSERM (the French National Institute of Health and Medical Research) and head of the Laboratory of Integrative Cancer Immunology at the Cordeliers Research Center in Paris. He is the cofounder of HalioDx and chairman of its scientific council.